{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:20:09Z","timestamp":1791991209926,"version":"4.4.0"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:p>\n                    Long-term peritoneal dialysis is associated with alterations in peritoneal function, like the development of high small solute transfer rates and impaired ultrafiltration. Also, morphologic changes can develop, the most prominent being loss of mesothelium, vasculopathy, and interstitial fibrosis. Current research suggests peritoneal inflammation as the driving force for these alterations. In this review, the available evidence for inflammation is examined and a new hypothesis is put forward consisting of high glucose-induced pseudohypoxia. Hypoxia of cells is characterized by a high (oxidized-reduced nicotinamide dinucleotide ratio) NADH-NAD\n                    <jats:sup>+<\/jats:sup>\n                    ratio in their cytosol. Pseudohypoxia is similar but occurs when excessive amounts of glucose are metabolized, as is the case for peritoneal interstitial cells in peritoneal dialysis. The glucose-induced high NADH-NAD\n                    <jats:sup>+<\/jats:sup>\n                    ratio upregulates the hypoxia-inducible factor-1 gene, which stimulates not only the glucose transporter-1 gene but also many profibrotic genes like TGF\n                    <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                    , vascular endothelial growth factor, plasminogen activator inhibitor-1, and connective tissue growth factor, all known to be involved in the development of peritoneal fibrosis. This review discusses the causes and consequences of pseudohypoxia in peritoneal dialysis and the available options for treatment and prevention. Reducing peritoneal exposure to the excessively high dialysate glucose load is the cornerstone to avoid the pseudohypoxia-induced alterations. This can partly be done by the use of icodextrin or by combinations of low molecular mass osmotic agents, all in a low dose. The addition of alanyl-glutamine to the dialysis solution needs further clinical investigation.\n                  <\/jats:p>","DOI":"10.2215\/cjn.15371121","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T12:02:25Z","timestamp":1644926545000},"page":"1259-1266","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":41,"title":["Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients"],"prefix":"10.2215","volume":"17","author":[{"given":"Raymond T.","family":"Krediet","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Parikova","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8]]},"reference":[{"key":"B1-20241015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3747\/pdi.2012.00189","article-title":"Longitudinal analysis of peritoneal fluid transport and its determinants in a cohort of incident peritoneal dialysis patients","volume":"34","author":"Coester","year":"2014","journal-title":"Perit Dial Int"},{"key":"B2-20241015","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1681\/ASN.2021010080","article-title":"Acquired decline in ultrafiltration in peritoneal dialysis: The role of glucose","volume":"32","author":"Krediet","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B3-20241015","article-title":"Do low GDP neutral pH solutions prevent or retard peritoneal membrane alterations in long-term peritoneal dialysis?","author":"Parikova","journal-title":"Perit Dial Int"},{"key":"B4-20241015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--An inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"B5-20241015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2362.1987.tb01224.x","article-title":"Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients","volume":"17","author":"Krediet","year":"1987","journal-title":"Eur J Clin Invest"},{"key":"B6-20241015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-2143(98)90047-6","article-title":"Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis?","volume":"132","author":"Douma","year":"1998","journal-title":"J Lab Clin Med"},{"key":"B7-20241015","first-page":"686","article-title":"Relationship of TNF-\u03b1, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis","volume":"122","author":"Zemel","year":"1993","journal-title":"J Lab Clin Med"},{"key":"B8-20241015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/089686080402400407","article-title":"Chronic inflammation in peritoneal dialysis: The search for the holy grail?","volume":"24","author":"Pecoits-Filho","year":"2004","journal-title":"Perit Dial Int"},{"key":"B9-20241015","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1681\/ASN.2013030314","article-title":"Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival","volume":"24","author":"Lambie","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B10-20241015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00002216-198907000-00134","article-title":"Splancnic volume, not flow rate determines peritoneal permeability","volume":"23","author":"Pietrzak","year":"1989","journal-title":"ASAIO Trans"},{"key":"B11-20241015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0896860819878344","article-title":"Advanced glycation end products are associated with immature angiogenesis and peritoneal dysfunction in patients on peritoneal dialysis","volume":"40","author":"Nakano","year":"2020","journal-title":"Perit Dial Int"},{"key":"B12-20241015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B13-20241015","first-page":"927","article-title":"Morphological changes of the peritoneal membrane in patients with long-term dialysis","volume":"55","author":"T\u0103ranu","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"B14-20241015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.kint.2018.02.022","article-title":"Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis","volume":"94","author":"Schaefer","year":"2018","journal-title":"Kidney Int"},{"key":"B15-20241015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphys.2019.00356","article-title":"Peritoneal dialysis vintage and glucose exposure but not peritonitis episodes drive peritoneal membrane transformation during the first years of PD","volume":"10","author":"Bartosova","year":"2019","journal-title":"Front Physiol"},{"key":"B16-20241015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0735-1097(98)00304-0","article-title":"Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: The remodeling paradox","volume":"32","author":"Pasterkamp","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"B17-20241015","first-page":"270","article-title":"Dialysate leucocytosis in CAPD patients without clinical infection","volume":"33","author":"Fijen","year":"1988","journal-title":"Neth J Med"},{"key":"B18-20241015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.1993.93","article-title":"Immuno-effector characteristics of peritoneal cells during CAPD treatment: A longitudinal study","volume":"43","author":"Betjes","year":"1993","journal-title":"Kidney Int"},{"key":"B19-20241015","doi-asserted-by":"crossref","first-page":"F229","DOI":"10.1152\/ajprenal.00274.2019","article-title":"Peritoneal dialysis induces alterations in the transcriptome of peritoneal cells before detectible peritoneal functional changes","volume":"318","author":"Parikova","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"B20-20241015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000183652","article-title":"Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients","volume":"42","author":"Krediet","year":"1986","journal-title":"Nephron"},{"key":"B21-20241015","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/oxfordjournals.ndt.a027465","article-title":"Effect of electric charge on the transperitoneal transport of plasma proteins during CAPD","volume":"11","author":"Buis","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"B22-20241015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-2143(99)90116-6","article-title":"Growth factors VEGF and TGF-\u03b21 in peritoneal dialysis","volume":"134","author":"Zweers","year":"1999","journal-title":"J Lab Clin Med"},{"key":"B23-20241015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3747\/pdi.2012.01063","article-title":"Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?","volume":"33","author":"Lopes Barreto","year":"2013","journal-title":"Perit Dial Int"},{"key":"B24-20241015","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1093\/ndt\/gfr170","article-title":"Variability of effluent cancer antigen 125 and interleukin-6 determination in peritoneal dialysis patients","volume":"26","author":"Lopes Barreto","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B25-20241015","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/17.8.1480","article-title":"Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate","volume":"17","author":"Pecoits-Filho","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B26-20241015","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/ndt\/gfp670","article-title":"Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients","volume":"25","author":"Oh","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B27-20241015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fphys.2019.00105","article-title":"Peritoneal protein clearance is a function of local inflammation and membrane area wheres systemic inflammation and comorbidity predict survival of incident peritoneal dialysis patients","volume":"10","author":"Yu","year":"2019","journal-title":"Front Physiol"},{"key":"B28-20241015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000099332","article-title":"Evaluation of peritoneal transport and membrane status in peritoneal dialysis: Focus on incident fast transporters","volume":"27","author":"Rodrigues","year":"2007","journal-title":"Am J Nephrol"},{"key":"B29-20241015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2369-15-8","article-title":"Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients","volume":"15","author":"Cho","year":"2014","journal-title":"BMC Nephrol"},{"key":"B30-20241015","first-page":"297","article-title":"Mathematical coupling of data. A common source of error","volume":"93","author":"Archie","year":"1981","journal-title":"Arch Surg"},{"key":"B31-20241015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-nutr-071812-161156","article-title":"Hypoxia and adipocyte physiology: Implications for adipose tissue dysfunction in obesity","volume":"34","author":"Trayhurn","year":"2014","journal-title":"Annu Rev Nutr"},{"key":"B32-20241015","first-page":"549412","article-title":"Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: Application and therapies","volume":"2015","author":"Zinna","year":"2015","journal-title":"BioMed Res Int"},{"key":"B33-20241015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00441-016-2461-3","article-title":"Hypoxia in tissue repair and fibrosis","volume":"365","author":"Darby","year":"2016","journal-title":"Cell Tissue Res"},{"key":"B34-20241015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.oraloncology.2018.03.004","article-title":"Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC","volume":"80","author":"Joseph","year":"2018","journal-title":"Oral Oncol"},{"key":"B35-20241015","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/diab.42.6.801","article-title":"Hyperglycemic pseudohypoxia and diabetic complications","volume":"42","author":"Williamson","year":"1993","journal-title":"Diabetes"},{"key":"B36-20241015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.yexcr.2017.03.007","article-title":"Hypoxia, pseudohypoxia and cellular differentiation","volume":"356","author":"Mohlin","year":"2017","journal-title":"Exp Cell Res"},{"key":"B37-20241015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12551-015-0186-2","article-title":"Glucose transporters: Physiological and pathological roles","volume":"8","author":"Navale","year":"2016","journal-title":"Biophys Rev"},{"key":"B38-20241015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cphy.c110024","article-title":"Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis","volume":"2","author":"Cura","year":"2012","journal-title":"Compr Physiol"},{"key":"B39-20241015","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ki.1992.121","article-title":"Diabetes-induced glomerular dysfunction: Links to a more reduced cytosolic ratio of NADH\/NAD+","volume":"41","author":"Tilton","year":"1992","journal-title":"Kidney Int"},{"key":"B40-20241015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/089686080302300507","article-title":"Peritoneal function and assessment of reference values using a 3.86% glucose solution","volume":"23","author":"Smit","year":"2003","journal-title":"Perit Dial Int"},{"issue":"Suppl 3","key":"B41-20241015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/17.suppl_3.16","article-title":"Clinical advantages of new peritoneal dialysis solutions","volume":"17","author":"Krediet","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B42-20241015","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.kint.2017.05.034","article-title":"The hallmarks of mitochondrial dysfunction in chronic kidney disease","volume":"92","author":"Galvan","year":"2017","journal-title":"Kidney Int"},{"key":"B43-20241015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/iub.572","article-title":"The monocarboxylate transporter family--Role and regulation","volume":"64","author":"Halestrap","year":"2012","journal-title":"IUBMB Life"},{"issue":"Suppl 3","key":"B44-20241015","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1177\/089686080502503S05","article-title":"Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution","volume":"25","author":"van Westrhenen","year":"2005","journal-title":"Perit Dial Int"},{"key":"B45-20241015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/089686080802800512","article-title":"A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solution","volume":"28","author":"van Westrhenen","year":"2008","journal-title":"Perit Dial Int"},{"key":"B46-20241015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1681\/ASN.V114717","article-title":"Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis","volume":"11","author":"Combet","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"B47-20241015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/0886022X.2015.1127741","article-title":"HIF-1\u03b1 mediates Hypoxia-induced epithelial-mesenchymal transition in peritoneal mesothelial cells","volume":"38","author":"Morishita","year":"2016","journal-title":"Ren Fail"},{"key":"B48-20241015","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.prp.2018.12.022","article-title":"HIF1A and VEGF regulate each other by competing endogenous RNA mechanism and involve in the pathogenesis of peritoneal fibrosis","volume":"215","author":"Li","year":"2019","journal-title":"Pathol Res Pract"},{"key":"B49-20241015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12967-021-02946-8","article-title":"Stat3\/HIF-1\u03b1 signaling activation mediates peritoneal fibrosis induced by high glucose","volume":"19","author":"Yang","year":"2021","journal-title":"J Transl Med"},{"key":"B50-20241015","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor \u03b2 in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N Engl J Med"},{"key":"B51-20241015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jcmm.13060","article-title":"Signalling pathways involved in hypoxia-induced renal fibrosis","volume":"21","author":"Liu","year":"2017","journal-title":"J Cell Mol Med"},{"key":"B52-20241015","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/01.ASN.0000065640.77499.D7","article-title":"Extracellular matrix metabolism in diabetic nephropathy","volume":"14","author":"Mason","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B53-20241015","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V12102029","article-title":"Gene transfer of transforming growth factor-\u03b21 to the rat peritoneum: Effects on membrane function","volume":"12","author":"Margetts","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B54-20241015","first-page":"1029","article-title":"Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis","volume":"146","author":"Dvorak","year":"1995","journal-title":"Am J Pathol"},{"key":"B55-20241015","first-page":"615","article-title":"Vascular endothelial growth factor. The trigger for neovascularization in the eye","volume":"72","author":"Ferrara","year":"1995","journal-title":"Lab Invest"},{"key":"B56-20241015","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1681\/ASN.V1281734","article-title":"Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane","volume":"12","author":"Vriese","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B57-20241015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1067\/mlc.2001.112235","article-title":"Vascular endothelial growth factor in peritoneal dialysis: A longitudinal follow-up","volume":"137","author":"Zweers","year":"2001","journal-title":"J Lab Clin Med"},{"key":"B58-20241015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.25796\/bdd.v3i4.55893","article-title":"Non-invasive measurement of peritoneal membrane alterations","volume":"3","author":"Parikova","year":"2020","journal-title":"Bull Dial Dom"},{"key":"B59-20241015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2004.00827.x","article-title":"Pleiotropic functions of plasminogen activator inhibitor-1","volume":"3","author":"Lijnen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"B60-20241015","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1253\/circj.72.844","article-title":"Effects of metabolic risk factors on production of plasminogen activator inhibitor-1 and adiponectin by adipocytes","volume":"72","author":"Sakamoto","year":"2008","journal-title":"Circ J"},{"key":"B61-20241015","doi-asserted-by":"crossref","first-page":"20180103","DOI":"10.1515\/pp-2018-0103","article-title":"Hypoxia, cytokines and stromal recruitment: Parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis","volume":"3","author":"Wilson","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"Suppl","key":"B62-20241015","first-page":"S11","article-title":"Plasminogen activator inhibitor-1 and diabetic nephropathy","volume":"10","author":"Lee","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"B63-20241015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcb.26146","article-title":"Plasminogen activator inhibitor type 1 as a regulator of fibrosis","volume":"119","author":"Rabieian","year":"2018","journal-title":"J Cell Biochem"},{"key":"B64-20241015","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.ajkd.2014.10.022","article-title":"Peritoneal effluent MMP-2 and PAI-1 in encapsulating peritoneal sclerosis","volume":"65","author":"Lopes Barreto","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B65-20241015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.matbio.2019.09.003","article-title":"Role of hypoxia in skeletal muscle fibrosis: Synergism between hypoxia and TGF-\u03b2 signaling upregulates CCN2\/CTGF expression specifically in muscle fibers","volume":"87","author":"Valle-Tenney","year":"2020","journal-title":"Matrix Biol"},{"key":"B66-20241015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000351989","article-title":"GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy","volume":"38","author":"Heilig","year":"2013","journal-title":"Am J Nephrol"},{"key":"B67-20241015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/039139880502800208","article-title":"Cytokines and growth factors involved in peritoneal fibrosis of peritoneal dialysis patients","volume":"28","author":"Oh","year":"2005","journal-title":"Int J Artif Organs"},{"key":"B68-20241015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1523-1755.2003.00069.x","article-title":"Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients","volume":"64","author":"Zarrinkalam","year":"2003","journal-title":"Kidney Int"},{"key":"B69-20241015","article-title":"Connective tissue growth factor (CTGF\/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate","author":"Mizutani","journal-title":"Am J Physiol Renal"},{"key":"B70-20241015","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1172\/JCI84431","article-title":"Hif1\u03b1 and metabolic reprogramming in inflammation","volume":"126","author":"Corcoran","year":"2016","journal-title":"J Clin Invest"},{"key":"B71-20241015","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/1933719118789511","article-title":"Evitar (L-Alanyl-L-Glutamine) regulates key signaling molecules in the pathogenesis of postoperative tissue fibrosis","volume":"26","author":"Robertson","year":"2019","journal-title":"Reprod Sci"},{"key":"B72-20241015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.kint.2015.12.005","article-title":"The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis","volume":"89","author":"Ferrantelli","year":"2016","journal-title":"Kidney Int"},{"key":"B73-20241015","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.kint.2018.08.031","article-title":"A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health","volume":"94","author":"Vychytil","year":"2018","journal-title":"Kidney Int"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.15371121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:30Z","timestamp":1786369530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.15371121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.15371121","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}